Pharmacogenetic study of autonomic nervous function in psychiatric patients

Pharmacogenetic study of autonomic nervous function in psychiatric patients - Pharmacogenetic study of autonomic nervous function in psychiatric patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007800

Enrollment

200

Registered

2012-04-20

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychiatric disease

Interventions

Genomic DNA was extracted from peripheral white blood cells from all patients using standard techniques.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects are psychiatric disease patients including schizophrenia and mood disorders. Control subjects are healthy subjects.

Exclusion criteria

Exclusion criteria: Patients with preexisting disease known to affect autonomic nervous system activity are excluded.

Design outcomes

Primary

Measure	Time frame
Level of psychiatric disease, body height/weight, autonomic nervous activity(ECG), genetic polymorphism	—

Countries

Japan

Contacts

Public ContactIkuko Kishida

Yokohama City University School of medicine Department of Psychiatry

kasuga@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026